ZA941426B - Recombinant viruses and their use in gene therapy - Google Patents

Recombinant viruses and their use in gene therapy

Info

Publication number
ZA941426B
ZA941426B ZA941426A ZA941426A ZA941426B ZA 941426 B ZA941426 B ZA 941426B ZA 941426 A ZA941426 A ZA 941426A ZA 941426 A ZA941426 A ZA 941426A ZA 941426 B ZA941426 B ZA 941426B
Authority
ZA
South Africa
Prior art keywords
gene therapy
recombinant viruses
preparing
disclosed
eye diseases
Prior art date
Application number
ZA941426A
Other languages
English (en)
Inventor
Pascale Briand
Michel Perricaudet
Original Assignee
Rhone Poulenc Rorer Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa, Inst Nat Sante Rech Med filed Critical Rhone Poulenc Rorer Sa
Publication of ZA941426B publication Critical patent/ZA941426B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA941426A 1993-03-03 1994-03-01 Recombinant viruses and their use in gene therapy ZA941426B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9302438A FR2702152B1 (fr) 1993-03-03 1993-03-03 Virus recombinants et leur utilisation en thérapie génique.

Publications (1)

Publication Number Publication Date
ZA941426B true ZA941426B (en) 1994-10-04

Family

ID=9444602

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941426A ZA941426B (en) 1993-03-03 1994-03-01 Recombinant viruses and their use in gene therapy

Country Status (15)

Country Link
EP (1) EP0687184B1 (pt)
JP (1) JP3835809B2 (pt)
AT (1) ATE220923T1 (pt)
AU (1) AU693782B2 (pt)
CA (1) CA2154355A1 (pt)
DE (1) DE69431046T2 (pt)
DK (1) DK0687184T3 (pt)
ES (1) ES2181710T3 (pt)
FR (1) FR2702152B1 (pt)
HU (1) HU218900B (pt)
NO (1) NO319571B1 (pt)
NZ (1) NZ262135A (pt)
PT (1) PT687184E (pt)
WO (1) WO1994020146A1 (pt)
ZA (1) ZA941426B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces
FR2726575B1 (fr) * 1994-11-09 1996-12-20 Rhone Poulenc Rorer Sa Virus recombinants, preparation et utilisation en therapie genique
IL113052A0 (en) * 1994-03-23 1995-06-29 Rhone Poulenc Rorer Sa Recombinant viruses, their preparation and their use in gene therapy
FR2717823B1 (fr) * 1994-03-23 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
FR2717824B1 (fr) * 1994-03-25 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
FR2718150B1 (fr) 1994-03-29 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
US5827702A (en) * 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
US6107027A (en) * 1994-12-14 2000-08-22 University Of Washington Ribozymes for treating hepatitis C
US6696423B1 (en) 1997-08-29 2004-02-24 Biogen, Inc. Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
US6489305B1 (en) 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
DE60022549T2 (de) * 1999-12-30 2006-05-18 Aventis Pharma S.A. Verwendung von einem für einem anti-angiogenen faktor codierenden vektor zur behandlung von vaskularisation der hornhaut
FR2803207B1 (fr) * 1999-12-30 2004-04-30 Aventis Pharma Sa Utilisation d'un vecteur comprenant un acide nucleique codant pour un facteur anti-angiogenique pour le traitement des neovascularisations corneennes
US6821775B1 (en) 2000-02-11 2004-11-23 Genvec, Inc. Viral vector encoding pigment epithelium-derived factor
US20030158112A1 (en) 2002-02-15 2003-08-21 Johns Hopkins University School Of Medicine Selective induction of apoptosis to treat ocular disease
NZ546983A (en) 2003-11-24 2009-05-31 Canji Inc Reduction of dermal scarring
CN101094688B (zh) 2004-09-13 2013-05-01 建新公司 多聚构建体
HRP20180154T1 (hr) 2010-08-06 2018-03-09 Genzyme Corporation Pripravci vegf antagonista i njihova uporaba

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0434750B1 (en) * 1988-09-13 1997-07-09 Biosource Technologies, Inc. Medicament for treating degenerative diseases of the nervous system
JPH06506599A (ja) * 1991-04-05 1994-07-28 エディソン　アニマル　バイオテクノロジー　センター，オハイオ　ユニバーシティー パッケージング配列に相補的なアンチセンス核酸によるレトロウイルスの抑制

Also Published As

Publication number Publication date
WO1994020146A1 (fr) 1994-09-15
ES2181710T3 (es) 2003-03-01
EP0687184A1 (fr) 1995-12-20
PT687184E (pt) 2002-12-31
NO953329L (no) 1995-08-24
NO953329D0 (no) 1995-08-24
HU218900B (hu) 2000-12-28
FR2702152A1 (fr) 1994-09-09
ATE220923T1 (de) 2002-08-15
CA2154355A1 (fr) 1994-09-15
NO319571B1 (no) 2005-08-29
DE69431046D1 (de) 2002-08-29
FR2702152B1 (fr) 1995-05-24
AU693782B2 (en) 1998-07-09
AU6144494A (en) 1994-09-26
HU9502573D0 (en) 1995-10-30
NZ262135A (en) 2000-12-22
JP3835809B2 (ja) 2006-10-18
DE69431046T2 (de) 2003-02-13
HUT73215A (en) 1996-06-28
JPH08509208A (ja) 1996-10-01
DK0687184T3 (da) 2002-10-28
EP0687184B1 (fr) 2002-07-24

Similar Documents

Publication Publication Date Title
HUT73215A (en) Recombinant adenoviruses and use thereof in gene therapy
ZA949104B (en) Recombinant viruses and their use in gene therapy
IL109644A0 (en) Viral vectors and their use in gene therapy
AU1000488A (en) A light ray radiation device for use in medical treatment of the nose and throat passages
AU586860B2 (en) Therapeutical application of phosphonylmethoxyalkyl adenines
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
ZA961153B (en) Process for preparing recombinant adenovirus genomes
IL111682A0 (en) Recombinant viruses and their use in gene therapy
DE69629570D1 (de) 3'utr des menschliches prohibitin-gens
GR3031354T3 (en) Soluble interferon -receptor, its preparation and use.
AU2894389A (en) Novel preparation and method of use thereof
SG50419A1 (en) Methods of therapeutic and anaesthetic treatment and preparations therefor
AU1898792A (en) Treatment or therapeutic booth for energetic, cosmetic and medical purposes
ZA952242B (en) Recombinant viruses their preparation and their use in gene therapy
GEP20012489B (en) Use of Natural Human α-Interferon
ZA952244B (en) Recombinant viruses their preparation and their use in gene therapy
EP0408525A3 (en) Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e)azepine-6,11-dione and derivatives as drugs for use in the treatment of urinary incontinence
AU7066794A (en) Hyaluronic acid fragments and their therapeutic use
HU913022D0 (en) Fibroplast increasing factor for treating and preventing virus caused diseases
AU3053595A (en) Therapeutic treatment and preparations
MX9706569A (es) Virus recombinantes que expresan la lecitina-colesterol aciltransferasa y sus usos en terapia genica.
ZA952286B (en) Recombinant viruses their preparation and their use in gene therapy
ZA952243B (en) Recombinant viruses their preparation and their use in gene therapy
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis